Representative Jefferson Shreve (R-Indiana) recently sold shares of Exponent, Inc. NASDAQ: EXPO. In a filing disclosed on June 22nd, the Representative disclosed that they had sold between $15,001 and $50,000 in Exponent stock on May 12th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.
Representative Jefferson Shreve also recently made the following trade(s):
- Sold $15,001 - $50,000 in shares of Hubbell NYSE: HUBB on 5/12/2025.
- Sold $50,001 - $100,000 in shares of Trane Technologies NYSE: TT on 5/12/2025.
- Sold $15,001 - $50,000 in shares of RTX NYSE: RTX on 5/12/2025.
- Sold $50,001 - $100,000 in shares of NiSource NYSE: NI on 5/12/2025.
- Sold $50,001 - $100,000 in shares of Johnson & Johnson NYSE: JNJ on 5/12/2025.
- Sold $15,001 - $50,000 in shares of AppLovin NASDAQ: APP on 5/12/2025.
- Sold $15,001 - $50,000 in shares of Fiserv NYSE: FI on 5/12/2025.
- Sold $15,001 - $50,000 in shares of CNO Financial Group NYSE: CNO on 5/12/2025.
- Sold $50,001 - $100,000 in shares of Cboe Global Markets NASDAQ: CBOE on 5/12/2025.
- Sold $15,001 - $50,000 in shares of Lam Research NASDAQ: LRCX on 5/12/2025.
Exponent Trading Up 0.1%
Shares of Exponent stock traded up $0.10 during trading hours on Friday, reaching $72.23. The stock had a trading volume of 194,610 shares, compared to its average volume of 265,517. The firm has a 50 day simple moving average of $75.56 and a two-hundred day simple moving average of $80.90. The firm has a market capitalization of $3.67 billion, a price-to-earnings ratio of 35.23 and a beta of 0.90. Exponent, Inc. has a 1 year low of $71.29 and a 1 year high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The company had revenue of $137.44 million for the quarter, compared to the consensus estimate of $134.63 million. Exponent had a return on equity of 25.33% and a net margin of 18.87%. The company's quarterly revenue was up .2% compared to the same quarter last year. During the same period last year, the business posted $0.59 EPS. Sell-side analysts forecast that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were issued a $0.30 dividend. The ex-dividend date was Friday, June 6th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.66%. Exponent's dividend payout ratio (DPR) is 58.54%.
Insider Activity at Exponent
In related news, VP John Pye sold 2,000 shares of the firm's stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total transaction of $152,640.00. Following the sale, the vice president directly owned 29,204 shares in the company, valued at approximately $2,228,849.28. This trade represents a 6.41% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Joseph Rakow sold 1,573 shares of Exponent stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total value of $122,253.56. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,267 shares of company stock worth $489,120. 1.60% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Exponent
Several hedge funds have recently modified their holdings of the stock. Sequoia Financial Advisors LLC purchased a new stake in shares of Exponent during the 2nd quarter valued at about $330,000. Vest Financial LLC purchased a new stake in shares of Exponent during the 2nd quarter valued at about $1,069,000. CWM LLC raised its holdings in shares of Exponent by 6.0% during the 2nd quarter. CWM LLC now owns 8,887 shares of the business services provider's stock valued at $664,000 after buying an additional 504 shares during the period. Vanguard Personalized Indexing Management LLC raised its holdings in shares of Exponent by 22.5% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 15,207 shares of the business services provider's stock valued at $1,136,000 after buying an additional 2,795 shares during the period. Finally, Inspire Investing LLC raised its holdings in shares of Exponent by 23.8% during the 2nd quarter. Inspire Investing LLC now owns 5,230 shares of the business services provider's stock valued at $391,000 after buying an additional 1,004 shares during the period. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
About Representative Shreve
Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election.
Email editor@ballotpedia.org to notify us of updates to this biography.
Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive.
Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
